SUZUKI RIKIO 鈴木利貴央

… Alternative Names

SUZUKI Rikio 鈴木利貴央

Less

Researcher Number	70514371
Other IDs
Affiliation (Current)	2025: 東海大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2024: 東海大学, 医学部, 准教授 2019 – 2021: 東海大学, 医学部, 講師 2018: 東海大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related Except Principal Investigator Basic Section 38050:Food sciences-related / Basic Section 52010:General internal medicine-related
Keywords	Principal Investigator FPPC / ニューロピリン1 / ボルテゾミブ耐性 / CDK5 / furin / 転換 / PI3K-AKT / 骨細胞 / 骨髄微小環境 / 骨芽細胞 … More / 骨髄間質細胞 / 薬剤耐性機序 / セマフォリン3A / 多発性骨髄腫 … More Except Principal Investigator 低襲撃的治療 / チロシンキナーゼ阻害薬（TKI） / Pterostilbene / BCR/ABL / 慢性骨髄性白血病（CML） / 低鉄環境 / Vitamin C / 中枢神経浸潤 / 難治性血液腫瘍 / VitaminC (VC) / 中枢神経系(CNS)へ浸潤したリンパ腫 / 鉄濃度 / 高濃度のVC(H-VC) / 中枢神経系リンパ腫 / 鉄除去 / 鉄キレート / 中枢神経悪性リンパ腫 / 抗腫瘍効果 / 高濃度ビタミンC Less

Development of a novel minimally invasive treatment for refractory and therapy-resistant hematological malignancies using food extracts.
- Principal Investigator
  
  川田浩志
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 38050:Food sciences-related
- Research Institution
  Tokai University
Development of less invasive treatment for central nervous system invasion of refractory hematologic malignancies.
- Principal Investigator
  
  KAWADA HIROSHI
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  Tokai University
Elucidation and overcoming of drug resistance mechanism mediated by semaphorin 3A signal in multiple myelomaPrincipal Investigator
- Principal Investigator
  
  SUZUKI Rikio
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Tokai University

All 2022 2021 2019

All Journal Article Presentation

[Journal Article] Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells2022
- Author(s)
  Kawakami Shohei、Tsuma-Kaneko Mitsuyo、Sawanobori Masakazu、Uno Tomoko、Nakamura Yoshihiko、Matsuzawa Hideyuki、Suzuki Rikio、Onizuka Makoto、Yahata Takashi、Naka Kazuhito、Ando Kiyoshi、Kawada Hiroshi
- Journal Title
  
  Scientific Reports
  
  Volume: 12 Issue: 1 Pages: 04654-1
- DOI
  10.1038/s41598-021-04654-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07897, KAKENHI-PROJECT-20H03517, KAKENHI-PROJECT-21K19353, KAKENHI-PROJECT-23K21386
[Journal Article] Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma2022
- Author(s)
  Rikio Suzuki, Yuka Kitamura, Daisuke Ogiya, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando
- Journal Title
  
  International journal of hematology
  
  Volume: 115 Issue: 2 Pages: 233-243
- DOI
  10.1007/s12185-021-03244-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K08373, KAKENHI-PROJECT-19K07897
[Journal Article] Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia2021
- Author(s)
  Hara Ryujiro、Onizuka Makoto、Kikkawa Eri、Shiraiwa Sawako、Harada Kaito、Aoyama Yasuyuki、Ogiya Daisuke、Toyosaki Masako、Suzuki Rikio、Machida Sinichiro、Ohmachi Ken、Ogawa Yoshiaki、Kawada Hiroshi、Matsushita Hiromichi、Ando Kiyoshi
- Journal Title
  
  Annals of Hematology
  
  Volume: 100 Issue: 10 Pages: 2479-2486
- DOI
  10.1007/s00277-021-04587-9
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07897, KAKENHI-PROJECT-19K07903
[Journal Article] The role of hypertension and renin-angiotensin-aldosterone system inhibitors in bleomycin-induced lung injury.2021
- Author(s)
  Hara R, Onizuka M, Shiraiwa S, Harada K, Aoyama Y, Ogiya D, Toyosaki M, Suzuki R, Machida S, Ohmachi K, Ogawa Y, Kawada H, Watanabe S, Miyajima A, Masuda R, Iwazaki M, Mikami M, Koike T, Mochizuki H, Ando K
- Journal Title
  
  Clinical lymphoma myeloma & leukemia
  
  Volume: 21 (4) Issue: 4 Pages: 321-327
- DOI
  10.1016/j.clml.2020.10.004
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17872, KAKENHI-PROJECT-19K07897, KAKENHI-PROJECT-16H06277
[Journal Article] Overcoming tyrosine kinase inhibitor resistance in transformed cell harboring SEPT9-ABL1 chimeric fusion protein.2019
- Author(s)
  Kawai H, Matsushita H, Suzuki R, Kitamura Y, Ogawa Y, Kawada H, Ando K.
- Journal Title
  
  Neoplasia
  
  Volume: 21 Issue: 8 Pages: 788-801
- DOI
  10.1016/j.neo.2019.06.001
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07903, KAKENHI-PROJECT-19K07897
[Presentation] 自家末梢血幹細胞移植施行後も末梢神経障害の改善が不良であったPOEMS症候群の一例.2021
- Author(s)
  扇屋大輔、水間敦士、岩田紫及、川上翔平、白岩佐和子、原隆二郎、鈴木利貴央、今関良子、瀧澤俊也、川田浩志、小川吉明、安藤潔．
- Organizer
  第43回日本造血細胞移植学会総会
- Data Source
  KAKENHI-PROJECT-19K07897

1. KAWADA HIROSHI (20276801)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
2. 安藤潔 (70176014)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
3. 鬼塚真仁 (80366012)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 原隆二郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. 松下弘道

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

SUZUKI RIKIO 鈴木 利貴央

SUZUKI Rikio 鈴木 利貴央

Research Projects

Research Products

Co-Researchers

Development of a novel minimally invasive treatment for refractory and therapy-resistant hematological malignancies using food extracts.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of less invasive treatment for central nervous system invasion of refractory hematologic malignancies.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation and overcoming of drug resistance mechanism mediated by semaphorin 3A signal in multiple myelomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The role of hypertension and renin-angiotensin-aldosterone system inhibitors in bleomycin-induced lung injury.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Overcoming tyrosine kinase inhibitor resistance in transformed cell harboring SEPT9-ABL1 chimeric fusion protein.2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] 自家末梢血幹細胞移植施行後も末梢神経障害の改善が不良であったPOEMS症候群の一例.2021

Author(s)

Organizer

Data Source

SUZUKI RIKIO 鈴木利貴央

SUZUKI Rikio 鈴木利貴央